NICE recommends thalidomide ahead of Velcade | InPharm

Links shared publicly online about this topic.

  • 117
    total visits

NICE recommends thalidomide ahead of Velcade | InPharm

inpharm.com —

NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for the rare bone marrow cancer disease multiple myeloma

View full resource at inpharm.com

Tags: Leprosy Medication, Cancer, Bone, Disease and Condition, Thalomid, Thalidomide, Johnson & Johnson, disease

  • Share

Most Recently Shared on July 27, 2011 at 10:03 am By:

Pharmafocus Pharmafocus

NICE recommends thalidomide ahead of Velcade http://ow.ly/5OkMo

9 months ago...

Reply

Retweet

Favorite

Advertisement